DAVOS, Switzerland (Reuters) - GlaxoSmithKline's chief executive, under pressure from some investors to break up the group, said on Thursday the drugmaker's large consumer healthcare unit had the potential to be a standalone unit at some stage.
http://ift.tt/1WxhPCG
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire